BackPhaseBio Pharmaceuticals Overview

PhaseBio Pharmaceuticals Research & Development

Research & Development expenses for PHAS.

Quarterly R&D Expenses

$20.94M
↓ 23.49% YoY

As of Jun 30, 2022

Annual R&D Expenses (TTM)

$-14308893.00
↓ 115.99% YoY

Trailing 12 months ending Jun 30, 2022

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin